Company facts
- Headquarters
- Salt Lake City, Utah
- Most recent report
- 10-Q, filed Nov 2, 2026
- Incorporated
- Delaware
- Filings on record
- 991 filings
- On EDGAR
- CIK 1601830
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 23
News 8 of 90
Prospectuses and Registrations 8 of 25
- 424B5 Prospectus supplement for an offering Oct 15, 2026
- 424B5 Prospectus supplement for an offering Oct 15, 2026
- S-8 Registration statement for an employee plan Feb 25, 2026
- 424B5 Prospectus supplement for an offering Feb 25, 2026
- S-8 Registration statement for an employee plan May 5, 2025
- 424B5 Prospectus supplement for an offering Feb 28, 2025
- S-3ASR Automatic shelf registration Feb 12, 2025
- S-8 Registration statement for an employee plan Nov 20, 2024
Proxies 8 of 22
- DEFA14A Extra proxy material Apr 30, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 30, 2026
- DEFA14A Extra proxy material Apr 28, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2025
- DEFA14A Extra proxy material Nov 6, 2024
- DEFA14A Extra proxy material Oct 30, 2024
- DEFM14A Oct 10, 2024
- DEFA14A Extra proxy material Sep 19, 2024
Ownership 8 of 791
- 4 Insider reported a trade Nov 4, 2026
- 4 Insider reported a trade Nov 4, 2026
- 3 Insider reported their initial holding Nov 4, 2026
- 144 Notice of a proposed sale of restricted stock Nov 3, 2026
- 4 Insider reported a trade Oct 7, 2026
- 4 Insider reported a trade Oct 7, 2026
- 144 Notice of a proposed sale of restricted stock Oct 6, 2026
- 144 Notice of a proposed sale of restricted stock Oct 6, 2026
Other 8 of 40
Everything here comes from Recursion Pharmaceuticals, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.